01149nas a2200277 4500000000100000008004100001260001300042653001200055653001100067653001200078653001900090653002200109653002700131653001900158653003600177653001600213653001900229653001600248100001300264700001500277245009300292300001000385490000700395520045500402022001400857 1980 d c1980 Feb10aDapsone10aHumans10aleprosy10aMotor Endplate10aNeural Conduction10aNeuromuscular Junction10aPeroneal Nerve10aRecruitment, Neurophysiological10aSulfadoxine10aSulfanilamides10aUlnar nerve1 aLinois H1 aSébille A00aElectrophysiological evidence for motor unit impairment during the treatment of leprosy. a57-630 v453 a

Although neuropathy is the most striking feature in leprosy, the effects of various drugs are usually assessed by dermatological and bacteriological improvement. This short term electrophysiological study shows that both antileprosy drugs, DDS and Sulforthomidine, do not affect the insidious deterioration of motor unit condition in lepromatous and borderline BT patients. Differences observed in the results of the two groups were discussed.

 a0022-510X